ECI Therapeutics
Elan Weiner is the Chief Executive Officer at ECI Therapeutics, a biopharma company specializing in specialty human plasma/serum-derived drugs for ophthalmic conditions, wound healing, and burns. Prior to this role, Elan served as Vice President Business Development & Strategic Collaborations and General Manager, Global Therapeutics at Cerus. Elan has a strong background in blood center services and clinical consulting, with experience at organizations like Fresenius Kabi USA and Community Blood Centers of South Florida. Elan holds a MS in Public Health from Emory University and an Executive MBA from Yale School of Management.
This person is not in any teams
This person is not in any offices
ECI Therapeutics
ECI is a biopharma company dedicated to the development, commercialization, and marketing of specialty human plasma/serum-derived drugs for ophthalmic conditions; wound healing; and burns. Leveraging a novel molecule to enhance consistency, and decrease the risk of pathogenicity, ECI seeks to harness the power of blood to heal.